SCHEMBL32688478

SCHEMBL32688478

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1cccc(C(=O)Nc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ACMSD Q8TDX5 5/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ADORA1 P30542 2/20 0.38
▸ MET P08581 2/20 0.37
▸ KDR P35968 2/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ LDHA P00338 2/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ PRKCA P17252 1/20 0.37
▸ GRK2 P25098 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688374 0.94 NPC1 (0.40) ALDH1A1NPC1HPGDTSHRRAB9A
SCHEMBL32688238 0.90 PTPN1 (0.39) NPC1HPGDRAB9ASMN1; SMN2ACMSD
SCHEMBL32688070 0.89 ACMSD (0.47) ACMSDMEN1POLBKMT2AADORA1
SCHEMBL32688271 0.88 ALDH1A1 (0.42) ALDH1A1NPC1HPGDTSHRRAB9A
SCHEMBL32688180 0.86 POLB (0.49) ALDH1A1NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL32688278 0.85 ACMSD (0.57) ALDH1A1HPGDACMSDMEN1POLB
SCHEMBL32688370 0.85 POLB (0.41) ALDH1A1HPGDACMSDMEN1POLB
SCHEMBL32688008 0.82 MEN1 (0.42) ALDH1A1HPGDACMSDMEN1POLB
SCHEMBL32688145 0.82 ACMSD (0.44) ACMSDMEN1POLBKMT2AADORA1
SCHEMBL32688221 0.81 SIRT2 (0.46) SMN1; SMN2MEN1POLBKMT2AMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885NPC1 1970/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback